the alzheimer's association. and now we're going to hear a little bit about the association's work from the president and ceo harry johns and here to lead the conference is the co-anchor the pbs news hour judy woodruff. judy, the floor is yours. >> thank you. thank you, margaret. i'm delighted to be here for this important conversation and really pleased to be able to have this discussion with harry johns. we've just been chatting about this. i want to say that i too -- i was listening to margaret. i have a personal connection. a close cousin whose wife has been diagnosed for a couple of years and i've seen perhaps as all of you have, perhaps the physical and the emotional and the personal toll this can take. and i want to launch right in with you harry johns and ask about the role of the alzheimer's association. how does the association fit into this big alzheimer's picture? we practically every day pick up the newspaper or look online and there another article or maybe another promising development out there ab

against alzheimer's, alzheimer's cures and all these groups. because raising public awareness is absolutely critical to getting the kind of support that we need. and that has been there for other diseases that have organized powerful advocacy groups that are willing to speak out. and that's what we need to do. but it's changing. i've been the chair of the alzheimer's task force in the senate for years. senator clinton was my first co-chair. i've always made it bipartisan. well, it's been quite a while since she's been in the senate. and so back then it was really difficult to get people interested. now i have people clamoring to be the co-chair. now senator warner is a co-chair, senator toomey is a co-chair. senator markey is a co-chair. that's a real difference. and that matters in terms of our ability to bring bipartisan efforts here. >> so you mentioned hillary clinton. we are entering a political season. and just about everyone you know is running for president. >> yes. >> do you think there's a chance -- >> i don't know donald trump. i wan

alzheimer's u.s. against alzheimer's cures and all these groups because raising public awareness is absolutely critical to getting the kind of support that we need and that has been there for other diseases that have organized powerful advocacy groups willing to speak out. and that's what we need to do. but it's change inging. i've been the chair of the alzheimer's task force in the senate for years. i've always made it bipartisan. it's been quite awhile since she's been in the senate and so back then it was really difficult to get people interested. now i have people clambering to be the co-chair. now senator warner is a co-chair, senator toomey is a co-chair, that's a real difference. and that matters in terms of our ability to bring bipartisan efforts. >> hillary clinton, we are entering a political season and just about everyone you know is running for president. do you think there's a chance? >> i don't know donald trump. i want to put that on the record. >> but in it, do you think there's a resp

alzheimer's is the sixth leading cause of death in the u.s. that disease and other forms of dementia take a devastating toll on patients, families and care give givers. it is dock meanted in this short film. >> my name is mary helen. i'm the mother of 12 children and i loved each one of them. i was born august 19, 1924, in north carolina. the south was always hard on blacks. they didn't want to feel that you were equal with them. but i always felt like i was as good as anybody else. i had no inferior complex at all. in fact i was a little arrogant. i thought i could do anything. ♪ >> in high school, we were -- i think we were in the -- what was it -- the tenth grade. she was so kind and so nice, you know. i proposed to her in a letter. i wrote her a letter. i was in new york and asked her if she would marry me and she wrote me back and said "yes." ♪ this one here, this is when we lived in lived on paris street and everyone was very, very young. that's george, carla, quinn. >> it started about ten years ago. i try not to show it, but i take

why has alzheimer's proven so tough? >> it is a complex diseases and that is what we discovered over the last decade that there are different risks and yours may be different than mine. so to untangle all of that has proven very difficult. it is likely treatments will be different for individuals it is more the precision that is in a little too late to identify the risk factors and then to actually attack those four different people. >> but that could be with cancer you don't fully understand that. >> cancer started in the 1970's but the center's program started in the mid-80s so we are behind to have the research efforts and so the focus has come later. >> this is what you have been focused:-- john but until relatively recently they did not think of it as the disease. the original patient had a very young onset of course, for days or 50s they see it as a disease but the medical community late '70s or '80s they thought it was inevitable that there is no way to intervene. but beginning in the '70s and '80s we understand t

we're doing more for alzheimer's disease is so inspiring. >> last we are we spent $140 billion on alzheimer's patients. and by the time all the baby boomers have retired, it's 15 or 16 million, which would raise the total cost up to $600 billion, which would be the same as the defense budget this year. >> the more the company public is aware, and it's just a decision that we have to make, the better off and the healthier america will be especially in terms of alzheimer's. so we could not be better served than glen cam bechl i mean getting on the stage and singing, that must be fun. right? coming to congressional offices -- [ laughter ] that's really generous. >> do you know where your playing tonight? where are you playing? >> the library of congress. >> that's right. >> you know, by the time i became governor in the late '70s, he was already a major figure in american music. and i knew that he was from the delight, which is close to where i grew up. he has brought a clarity to this issue. we don't spend nearly enough money on alzheimer's research. we don't really have any way of slowing the

there isn't an awareness of the prevalence of alzheimer's. partially because people used to die earlier and also people would say she has got to do and senile aunt they didn't realize that was the disease. raising public awareness is critical to get that type of support that has been there for other diseases to those powerful advocacy groups that is what we need to do. senator clinton was my first co-chair. has ben a while since she was in the senate but back then it was difficult now i have people clamoring to be that co-chair. now senator warner it is a real difference. to bring bipartisan efforts. >> we're in a jury a political season just about everybody know was running for president. >> i don't know donald trump [laughter] >> is there a responsible way to elevate? to talk about silly stuff but is there a chance to bring those issues to the broader discussion? >> jeb bush called me to ask for my support. i am endorsing him but i took the opportunity to talk to him about alzheimer's i had him on the phone. >> that is a treatable moment if

a rare piece of good news in the fight against alzheimer's. a new drug shows promising signs of tackling the disease in its early stages. a dashcam video showing the unrest of a black woman in texas raises questions about her death in police custody -- showing the arrest of a black woman in texas raises questions about her death in police custody. and, how a show in washington appeals to a younger audience. ♪ katty: welcome to our viewers on public television in america and around the world. right now, 44 million people across the world are suffering from dementia. that number will grow as populations age. researchers in the united states have had encouraging results from a drug trial suggesting a new medication could slow the progress of alzheimer's if it is taken in the early stages. our correspondent has the details. >> alzheimer's has devastating consequences. contrast the healthy brain on the right with another ravaged by the disease. the brain shrinks, tissue dies memory and cognitive functions decline. >> what we could do is to go to

. >>> women and alzheimer's. why doctors now say women with certain early warning signs are declining twice as fast as men. the red flags you should be on the lookout for. >>> and hacking into your car. taking control while you're driving. the alarming new video that has one major car company taking action tonight to fix a stunning problem. "nightly news" begins right now. >> announcer: from nbc news world headquarters in new york this is "nbc nightly news with lester holt." >>> good evening and good luck to republican presidential contenders desperately trying to be heard above donald trump, who today again managed to provoke outrage and drive a lot of the discussion online by publicly revealing the personal phone number of opponent and senator lindsey graham. the stunt also managed to overshadow the entrance into the race today of ohio governor john kasich. trump remains atop the polls, and while some dismiss his success as short-lived and the direct result of media exposure others wonder whether his brash appr

population will increase the number of people with alzheimer's disease. the alzheimer's association international conference is going on right now here in the district. to talk more about some of the new findings being released this week is dr. james fixel, director of the inova center. thank you very much for being here with us. a new more than 28 million americans affected by alzheimer's in the next 30 years. that's a large number. how much of a burden is this going to place on medicare? >> it will abhuge burden in terms of the direct cost caring for those people, not only caring for dementia but all the complications that come as a part of that when people become immobile. >> how far away are we from solutions that may be able to slow the onset of the disease or prevent it in fact. >> i fish i could say we were really close. the biggest thing happening in the field is a better understanding of the early manifestations of the disease, mile markers, and a big thought about why some of our treatments have failed till now, is maybe we're implementing them

drugs. ♪ ♪ >>> alzheimer's, it affects more than 5 million americans today. it is the country's sixth most deadly disease. and yet finding a cure or a treatment that slows the progression of the ailment has proved illusive now as meg terrell reports, there appears to be new hope. >> the quest to develop a drug that actually slows the course of alzheimer's disease has been a long one, marked by failure. since 1998 123 drugs have failed in development. just four were approved. none slowed the declines in memory loss and sinking clearly that characterized alzheimer's. this year though new hope has bloomed. >> the sign of the community has been given a boost by some recent positive news of different drugs. we are all very hopeful at this time, more hopeful than we have been before. >> experimental medicines are under the spotlight this week with new data coming wednesday at the alzheimer's association international conference in washington, d.c.. they work to remove the plaque buildups in the brain, thought to be toxic to neurons. evidence from early studies show

to my father who is 88 years old and has alzheimer's. and my challenge is we are raising money and i think it is wonderful for research. because i don't want any other families to go through what we have gone through with her father. at the same time i want to be able to see that my father lives a life of dignity. up to this point he was an active gentleman and very happy and charismatic. where does the money come from and how do we get the different nursing homes and care facilities and in-home care to meet the requirements to continue to treat people with dignity. because i feel that as we have been talking to some of the other caregivers, that that is one of the things that there's no standard and is a very high turnover rate and i've been very fortunate and have found an amazing place that i hope others can find and then i hear horror stories about what is out there. so when you talk about the affordable health care and how we all deserve it, i also think that people who have served in the war as my father had and supported his famil

exactly. >> woodruff: keith fargo with the alzheimer's associations. we thank you. >> thank you. >> ifill: it's likely that everyone watching has spent time in a classroom, either as a student or a teacher. at 3.1 million, school teachers make up one of the largest portions of the american workforce. and because teacher turnover is very high, there are probably even more former teachers. the newshour's special correspondent for education, john merrow, has the story. >> reporter: it's graduation day for students at montclair state university, which has one of the largest schools of education in new jersey. >> it gives me pleasure to state that 665 members of this class are certified and qualified to teach in the public schools of the state of new jersey. >> reporter: these graduates are among the more than 200,000 women and men who've just completed teacher preparation programs across the country. >> i'm trying to find a job in elementary education k-6. >> i'm a math major, want to be a math teacher. >> certified in special education, i would like a tea

they hope the discoveries will lead to a delay in the onset of alzheimer's. monica malpass joins us live with more in the special fill lye leading the way. >> almost half will develop alzheimer's disease, a debilitating condition. philadelphia scientists are among those working harder than ever to stop it. >> this is a dream of all scientists. >> each day scientists test alzheimer's-damaged brains looking for key issues in the lab at the university of pennsylvania. researchers, dr. virginia lee and dr. john led the way as part of a group of experts. they discovered that proteins get misfolded causes information get spread from cell to cell. and knowing that it may be possible to stop the cell-to-cell spread. >> we target it and figure out a way to either unfold it or snag it with antibodies and throw it in the trash can. >> if they succeed with theories on mice it may lead to a human application. even if they swap it for five years it could effectively be a cure for alzheimer's. and a retired scientists who now has alzheimer's would love to see that happen. >

medicare program for seniors will have to be spent on alzheimer's care. that prospect is spurring congress to boost research spending by more than 50%. private funding is growing too. >> we are the largest nonprofit funders in the world. that kind of investment is so important as a compliment as well. that private philanthropy can move quickly and develop opportunities with speed. that's just what we need. >> the government's goal, to have an effective treatment for alzheimer's ready within the next ten years. >>> the scientists trying to find out how bacteria evolves so they can develop better medicines to fight them. there are concerns that super bugs could become more powerful than cancer. it's thought that bugs kill around a quarter of a million people every year. but without vital action, that number could rise to 10 million by the year 2015. in the first of our series on superbugs, we have been to a research center in southern england. >> you might not realize it, but you are looking at a medical revolution. when it comes to diseases, researchers he

the data was made public at the alzheimer's association's international conference here in washington d.c. >> this is actually just looking at the boomer population because we know the boomer population is almost 80 million today and they're moving through the age of highest risk. >> reporter: new treatment that can delay the onset of alzheimer's by just five years could cut the number of people who have the disease by 42%. that would save $220 billion in medicare costs. >> what that means is really that there's an urgency to find an answer, not only an early therapeutic but an early diagnostic for this disease. >> reporter: 2/3 of americans with alzheimer's are women. new research sheds light on the differences between men and women with the condition. amy osler was diagnosed with early onset alzheimer's at age 50. >> there's a part that's very lonely. there's a part that i can't share because i don't know how to share. >> postoperatively after surgery both men and women decline, but women decline twice as fast as men do. >> reporter: andrea roane, wusa9. >> the alzheimer's associati

she is alzheimer's as well. i'm one of 65000 alzheimer's caregivers in the state of new hampshire. one in five medicare dollars is spent on caring for someone with alzheimer's disease. the projections are by 2050 -- thank you. [applause] >> by 2050, the projections are by 2050 28 million baby boomers will have alzheimer's. i know firsthand the pain of seeing these people slip away. i know firsthand the financial burden this carries with it to families, to care for people as well as our country so my question to you is what will you do to make sure this devastating disease gets the attention it deserves? and also the potential to bankruptcy medicare and medicaid that they get the attention they deserve? >> first of all when i was in congress and we were balancing budgets, because i don't think about the budget you just go and slash everything. you've got to figure out how to make things work better. some things had to go because it's like a garage sale. you clean out your house i don't know why this is here. most of what you have just needs to be shined up. so newt gingrich has just

i chaired the alzheimer's group for a few years. americans will spend $20 trillion on alzheimer's and other dementias. that is more than a full year's ddp. imagine -- more than a full the taxpayers are on the hook for much of it includinging a 420% increase to medicare, and 330% increase to medicaid. these are two out of many. the federal funding for research to cure alzheimer's is only a tiny fraction of the money the government is already spending to treat alzheimer's every year. the nih grants sunday $1 million on dementia research this year less than one half of 1% of the $154 billion medicare and medicaid are spending to treat it. part of the reason for the imbalance is that nih funding has been cut more than 20% in real terms since 2003. given the costs we know are coming, boosting research funding may be the most fiscally responsible step we can take. i want to emphasize this for a second -- one of the places i bring a unique background -- we balance the federal budget for four straight years. we did it while doubling the nih

there is a lot of excitement with alzheimer's. people are saying if you scoop that little bit of analoid out of the brain, maybe the cognitive function does improve. >> that is key when you look at the early stage drugs biogen and lilly have. >> biogen everybody was excited about their phase 1-b data. we'll get more looks wednesday. lilly moved its drug which looked like it failed in an earlier study. now they reparsed that data. the patients some of them might not have had alzheimer's. that is why people think biogen was successful. they determined the patients had the plaques in the brain. that is going into phase three. >> federal dollars for research. how much now for alzheimer's? >> $560 million. >> how much for cancer? >> more than $5 billion. >> those are apples and oranges. cancer is a horrible problem. >> you were comparing it to hiv and how much strides we made. >> the hiv mentality started in the mid '80s. such a horrible problem and in two decades it became a manageable condition. we need to have a war on alzheimer's m

>> reporter: first, put alzheimer's into perspective. in the united states 5.3 million people are currently living with the disease and that number is expected to triple by 2050 according to the alzheimer's association. as baby boomers age the problem will just get bigger. 28 million baby boomers will develop alzheimer's between now and mid century. currently it is the sixth leading cause of death here in the u.s. so drug development is extremely crucial. but people are more optimistic than i've heard because of new drugs in the pipeline. let's look at how they work. alzheimer's disease is characterized by buildups of black in the brain called beta amayloid, key for memory and thinking. medicines currently on the market may temporarily alleviate symptoms of alzheimer's. by increasing levels of certain brain chemicals. but they don't reduce the black buildup associated with the disease. new streermtal drugs from eli lilly lilly, biogen aim the black it selves reducing the beta-amyloid hoping this will slow the cognitive declines that are

is already spending to treat alzheimer's every year. the nih spent $731 million on dementia research this year, less than one half of 1% of the $154 billion medicare and medicaid are spending to treat it in the same period. part of the reason for the imbalance is that national institute of health funding has been cut more than 20% in real terms since 2003, the end of the five-year doubling of the nih budget which we achieved in a bipartisan basis in the 1990s. given the cost are coming boosting research funding may be the most fiscally responsible step we can take. and i want to emphasis this for a second. this is where i do bring a unique back ground. we balanced the federal budget for four straight years. the only time in your lifetime the federal budget has been balanced for four straight years and we did it by doubling the nih budget. because we set priorities. but with the baby boomers aging, if we do not find a research-based solution, we will never balance the federal budget because we will never impose the level of regulatory pa

. >> a new drug may slow progression of alzheimer's disease. there has been a slow down in mental decline when taking the drug compared to taking a placebo. >>> with us now is head of political alzheimer's disease your research in u.k. the reason why this drug is so interesting and exciting is the fact that it slows down the progression of alzheimer's disease as opposed to just treating symptoms. >> that's right. i think the watch words tonight is cautious optimism. i think what we've seen is this developed. it does slow progression for people in the early stages of alzheimer's. these are interim results and we won't know for certain if it has these effects until we see the reports. and until that time we won't know for certain that this is having the effect and if it does show the same results that we see today in 18 months time then we really will have a breakthrough. a drug that is modifying the disease, slowing it down. >> what is interesting about this drug, it was only when they looked at it and tried it out on patients with the very firs

but two of the senators had a personal relationship with alzheimer's. suddenly you had people going, let me get this straight, it's going to create jobs it's the right thing to do for disease and it's the only possible strategy to balance the federal guj et. and somehow that conversation broke through. i mean i'm frankly trying to figure out how we get into the presidential campaign next year, i would love to have the candidates answer the question are you prepared -- are you going to try to get to a balanced budget by depriving people of goods and services? or are you going to invest in the research that lets us break free? if you postpone alzheimer's onset by five years you cut the projection in half. that's $10 trillion, there are not many places you can turn and say, i think i can take $10 trillion in a spending stream, in a positive way by keeping you healthier. >> let me follow up on this now speaker gingrich. you're conservative, may have a little more correct than i do in some circles on the question of the role of government here. why isn't it

alzheimer's is the holy grail. i mean, that is the holy grail. i don't think anybody's as close as some of these stocks would like lend itself to think that they are. but somebody's going to unravel this. will it be pfizer? i don't know. but i do think pfizer rallies into earnings. >> here's the interesting thing about this particular company. they went through trials years ago in 2011, 2012 and did not progress because it did not quite get to the levels they needed to yet they have stuck with it, put money into it and as guy mentioned $20 billion. holy smokes. if they can get there, this is huge. >> still ahead chipotle on deck to report earnings tomorrow night but just how does its famed burrito stack up against the competition? it is a major burrito blowout. in a blind taste test. much more "fast money" straight ahead. ♪ ♪ ♪ get excited for the 1989 world tour with exclusive behind the scenes footage, all of taylor swift's music videos, interviews, and more. xfinity is the destination for all things taylor swift. >>> welcome back. chipot

but most women never develop alzheimer's despite falling hormone levels so the answer is unlikely to be simple. >> rose: apple's stocks slipped sharply. uncertainty over the apple watch prompted a sell-off. the company lost $62 billion in value in after-hours trading. still ahead, a battle for the streets between uber and the yellow cab companies and two princes with a special reason to smile when the "cbs evening news" continues. introducing the first ever gummy multivitamin from centrum. a complete, and tasty new way to support... your energy... immunity... and metabolism like never before. centrum multigummies. see gummies in a whole new light. feeling intense knee pain? did you know it may be coming from being on your feet all day? dr. scholl's custom fit orthotic inserts are uniquely designed to provide immediate all day relief from knee pain. if you have moderate to severe plaque psoriasis. isn't it time to let the real you shine through? introducing otezla apremilast. otezla is not an injection or a cream. it's a pill that treats plaque psoriasis differently. some people who t

let's walk together to make an even bigger impact and end alzheimer's for good. find your walk near you at alz.org/walk. >>> well, it has happened again. a drone hovering where it shouldn't be, close to a us airways jet trying to land. the pilot forced to radio in for help and it is happening more often than you may think. tonight, new worries about the dangers of these remote-controlled gadgets flying way too close to your flight. here's abc's aditi roy. >> reporter: the federal aviation administration is investigating a close call for a us airways flight and a drone flying dangerously near one another. >> it was about 2,100 feet and it was just off of our left side and maybe 100 feet away? >> reporter: the pilot spotting the drone while landing at the charlotte airport wednesday. the wayward quad copterovering 2,100 feet in the air, according to the faa, and violating their rules which say, drones must stay 400 feet above ground, at least five miles from airports and well clear of aircraft. >> the reason that we don't want a drone anywhere close to commercial a

a los 65 aÑos una de cada seis mujeres tienen la posibilidad de desarrollar alzheimer en comparaciÓn con uno de cada 11 hombres. cientÍficos aseguran que esto comienza mucho antes de la apariciÓn de los sÍntomas de la dolencia. >> tenemos 80 millones de personas que entran en la edad de mÁs alto riesgo para la enfermedad. 65 aÑos. este grupo de 80 millones de personas mÁs de 28 millones van a ser afectados por esta enfermedad que tenemos, esto puede ser devastador que tenemos que buscar un tratamiento para poder disminuir los efectos, pero en los costos asociados con esta enfermedad que son altos. ana: la detecciÓn temprana es sumamente importante pero tambiÉn los cambios en el estilo de vida pueden ayudar a prevenir la enfermedad.. >> podemos cambiar los hÁbitos y por ejemplo ser mÁs activos, disminuir las horas en frente de la televisiÓn o juegos electrÓnicos y dormir mejor. Éstos son recomendaciones que podemos hacer, mantenernos activos. ana: la asociaciÓn tiene la esperanza de poder ver cambios antes de perder la memoria. reportero: no se muevan porque tengo todo l

another reason to get some zs because losing sleep could increase your risk of alzheimers. in calling for action on climate change. new research suggests there is a link between not getting enough sleep and the risk of getting alzheimers. the advice has always been to get seven or eight hours of sleep. this new rearming suggests your brain will pay the price. >> the pain clears toxins that result from work, differently. and sleep is really key to clearing those toxins from the pain. john hopkins researchers studying 70 older adults they found those that got the at least sleep or who have slept than those who slept over seven hours a night. in order to clear out the toxic protein, and to prevent the plaque it forms. >> deep sleep not rim sleep is key for this particular activity. in terms of getting rid of those toxins so if you don't get enough of that deep sleep, you won't be able to ward yourself off against alzheimers. >> how do you know if you are getting quality sleep? if you don't wake up feeling refreshed, you should see a doctor to check for other problems. without

with respect specifically alzheimer's i am 100% committed to increasing the research that goes and alzheimer's. one of the real unfortunate setbacks from the cutbacks in the congress is that so much of the health research done by the national institute of health and other first-rate research institutions has been cut back. i was talking to a scientist the other day who said that when the congress cut the money for the nih and others literally labs were close young scientists were laid off and it stopped progress in a number of very important efforts including with respect to alzheimer's. we have to get back funding our research and science agenda and in particular our research into diseases like alzheimer's because we are we're going to be on the brink of making some breakthroughs secondly, i think we have got to do more within the government programs, particularly medicare to provide more support for caregiving that is given by relative. now, people worry, how do you make the judgment. we couldwe could pay for a visiting nurse, pay for somebody coming in from the outside but how do we provide

selling that thing off. >> indeed when you think about alzheimer's families with people who have alzheimer's, they're looking at it would stop in patience. the tests were not as positive and conclusive as they hope. analysts think it's a better than 50% chance for the win and then chipotle. it turns out it had a wild ride. revenue disappointed profits, traded down to 623 in the after hours, 100 less than where it is now. and today on the after hours, volatile, but this morning, about 7% positive comments from the likes of j.p. morgan or 750 target. stuart: stocks disappoint and sells off afterwards down to 6.23 and opens up with a gain at 7.20. i'd love to know. >> disappointment and the analyst expectations. tune in at 5:00 eastern time with lauren sandra and nicole a great show fbn a.m. seriously, it's a great show i watch it every moment. accusing live -- >> and the same was settled in 2010. they make claims they can get your personal information safe from hackers and fcc says no we don't think you're able to do that. the ftc says you're doing it again and it's not secure enough and misle

lechleit er about alzheimer's and the amazing story of the company. we need to go to top headlines now. vonnie: the greek parliament working overtime today to clear the way for talks on a third bailout. in athens, lawmakers approved another round of creditor demands. prime minister alexis tsipras needed that legislation to pass so it could begin negotiations for a 93 billion dollar loan. the european commission said those talks should begin soon. it is a deal that will create the largest -- in the u.s. anthem is near an agreement to buy cigna. the price? about $48 billion. that announcement could come later this week. earlier this month, another big taker with aetna agreeing to buy humana. pearson is in advanced talks to sell to the "financial times." pearson said no guarantee that the top slowly to a sale. they started exploring the sale to the "ft" after being approached by several buyers. donald trump has called immigrants who have crossed the border "criminals and rapists." he will be at the border. his financial disclosure forms as he earns money

first on wednesday the company provided a long awaited update on that alzheimer's drug and the results were i think mixed to good. patients showed a slight improvement in cognition versus those who got the placebo and the reduction in amyloid plaque which is good. it didn't show that kind of improvement that so many bulls were hoping for. which is why the results were widely seen as disappointing. the data showed that the form you lakes -- formulation had a 50/50 chance of working. so no surprise biogen tumbled 35 points or nearly 6% over the course of last wednesday and thursday. suddenly biogen no longer has a red hot alzheimer's story, but hey at least there's the 14 to 16% growth forecast driven by the ms drug, right, right? but the stroke formulation, right? wrong. because when biogen reported on friday, the company dropped a bomb. because even though they beat wall street's earnings estimates for the quarter, management dramatically cut their full year sales and earnings forecast. instead of revenue growth in the 14 to 16% range that i mentioned four times biogen is looking for 6

asociacin alzheimer in; desafortunadamente ... nuestro riesgo. el alzheimer es la forma mas comn de la demencia. uno no piensa en el cerebro. controla todo lo demas. hasta el momento no hay una cura para esta enfermedad pero se han hecho muchos avances y como podramos a reducir los riesgos de que se desarrolle. no hay cura para ... al envejecer. la doctora carrillo, asegura que las personas tienen que empezar a cuidarse desde jvenes. es importante desde... al envejecer. la asociacin de alzheimer, ha creado una lista de seÑales de advertencia de la enfermedad.. -cambios de memoria que dificultan la vida cotidiana. -dificultad para planificar o resolver problemas. -dificultad para desempeÑar tareas habituales en la casa, en el trabajo o en su tiempo libre. - cambios en el humor o la personalidad blanca --- gelogos indican que pequeÑos temblores como el de ayer en fremont, pueden ser indcio de que un gran terremoto est por venir. take vo ---aseguran que la parte sur de la falla de san andres situada en el valle imperial, sufre rupturas cada 200 a

simply better. >>> dementia and alzheimer's construct the life from those who suffer from it. a program is helping those patients reconnect. now that same program needs your help >> we got closer look. tom i know this story hits home for you >> it does indeed, even when she had advanced alzheimer's shortly before my mother's death , she could still sing elvis presley's now our number word for word -- presley's song word for word. you can help patients reconnect with reality. we begin with clips from michael rosado bennetts called alive inside. >>reporter: henry, wracked by dementia it was isolated and alone in his all world -- in his own world, far different from the man he was >> he was always fun-loving and singing. he says -- he used to walk us and stop and sing in the rain and need to have as jumping and swinging around poles >> let's try your music. >>reporter: then a modern-day miracle. >> [music] >> and immediately he lights up. his eyes open wide >> he's always on the unit with his head like this >> the miracle continues when he's asked questions including do you like

. >>> big time for alzheimer's. eli lilly and biogen both out with highly anticipated data from their alzheimer's drug trials. >> start with biogen shares coming under some pressure today on what some are calling controversial results from its alzheimer's testing. importantly it seemed to slow cognitive declines when you looked apartment the trial more effectively at higher doses. there was one closely watched middle dose which did not show statistical significance in two measures on cognition. that's why some folks are disappointed in this data. a lot of analysts say this changes nothing but piper jaffray did downgrade the stock calling the data sloppy, loafer lowering its stock price to $410. eli lilly has recovered some of the losses earlier in the day, trading about flat now. analysts say the data on a similar drug came about in line with expectations. a lot more going on. we'll tell you more in the next hour. >>> let's get back out to what's happening with housing with existing home sales nearing 8 1/2-year hig

. ® tour as country music star battled alzheimers. every 67 seconds some one in the united states is diagnosed with the disease. what exactly happens to the brain as alzheimers progresses? here's dr. sanjay gupta. >> reporter: it only weighs 3 pounds texture like jelly and tons of wrinkles. yet that pint-sized prune of a brain is the most amazing powerful organ in your entire body when it is working right. when it is not, as in alzheimers disease, the results can be devastating. take a look here. the brain on left that's there mall. the one on the right, has advanced alzheimers. here is another view. see how the brain shrinks and fluid filled spaces expand. that's alzheimers crippling the ability to think and to plan. and also look here at the hipocampus. it shrivels. the sea horse structure allows us to form new memories and the first to disintegrate. how does this all happen? it starts inside the wrinkled part of the brain the cortex where billions of brain cells interconnecting trillions of ways to create the nureuron forests. elec